Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Management of Insomnia

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Nociception

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Acute Inflammation III: Local and Systemic Effects

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...

Sedatives and Hypnotics: Overview

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterization of SF3B1 role in prolactin-secreting pituitary tumors.

Endocrine-related cancer·2026

Same author

Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. <i>Cells</i> 2023, <i>12</i>, 1040.

Cells·2026

Same author

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence.

Pharmacology research & perspectives·2026

Same author

Nrf2/NOX2 Pathway Dysregulation and Oxidative Stress Biomarkers in Gaucher Disease-Associated Parkinsonism: Insights Into a Potential Therapeutic Target.

Journal of cellular and molecular medicine·2026

Same author

Integrative multidisciplinary oncological approach in cancer patients receiving oncological treatments: a case series.

Frontiers in pharmacology·2026

Same author

RETRACTED: Scuderi et al. Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 2269.

International journal of molecular sciences·2026

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Melatonin reduces hyperalgesia associated with inflammation.

Emanuela Esposito¹, Irene Paterniti, Emanuela Mazzon

¹IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Italy.

Journal of Pineal Research

|July 30, 2010

Summary

This summary is machine-generated.

Melatonin effectively reduced inflammation-induced hyperalgesia in rats by blocking pain pathways. This study highlights melatonin

More Related Videos

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Published on: June 13, 2025

Related Experiment Videos

Last Updated: Jun 10, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement

Published on: June 13, 2025

Area of Science:

Pharmacology
Neuroscience
Inflammation Research

Background:

Inflammation significantly alters pain perception, a process targeted by anti-inflammatory drugs.
Melatonin exhibits anti-inflammatory properties in animal models, but its effect on inflammation-induced hyperalgesia is less understood.
Hyperalgesia, an amplified pain response, can develop secondary to inflammatory conditions.

Purpose of the Study:

To investigate the potential of melatonin to reverse hyperalgesia associated with inflammation.
To explore the underlying mechanisms of melatonin's antihyperalgesic effects in an established rat model.

Main Methods:

Induced hyperalgesia in rats via subplantar injection of superoxide anion radical (O(2)(˙-)) to generate peroxynitrite.
Administered varying doses of melatonin (25-100 mg/kg) intraperitoneally prior to O(2)(˙-) exposure.
Assessed thermal hyperalgesia by measuring paw withdrawal latency and analyzed paw tissue for inflammation markers and protein nitration.

Main Results:

Melatonin dose-dependently attenuated the hyperalgesic responses induced by O(2)(˙-).
A dose of 100 mg/kg melatonin significantly reduced tissue damage and inflammation.
Melatonin blocked protein nitration, cyclooxygenase-2, and inducible nitric oxide synthase expression, and inhibited superoxide-driven PARP activation.

Conclusions:

Melatonin demonstrates significant potential in ameliorating hyperalgesia secondary to inflammation.
The antihyperalgesic effects are partly mediated through the inhibition of inflammatory pathways, including mitogen-activated protein kinase and NF-κB.
Melatonin's ability to inhibit peroxynitrite formation and subsequent molecular damage contributes to its therapeutic promise.